Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Decisional Conflict and Needs Assessment in Asthma Management

This study has been completed.
Centre Hospitalier Universitaire de Québec, CHU de Québec
AllerGen NCE Inc.
Information provided by (Responsible Party):
Louis-Philippe Boulet, Laval University Identifier:
First received: October 4, 2011
Last updated: May 24, 2013
Last verified: May 2013

Many patients suffering from asthma are not compliant to their treatment and consequently, are not well controlled. Shared decision making intervention has shown an improvement in the outcome of patients with chronic disease. The aim of this study is to evaluate decisional conflict and to assess decisional needs of adults with asthma.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Decisional Conflict and Needs Assessment in Shared Decision Making in Asthma Management

Resource links provided by NLM:

Further study details as provided by Laval University:

Primary Outcome Measures:
  • Measuring Decisional Conflict with a valid Decisional Conflict Scale [ Time Frame: 6 month ] [ Designated as safety issue: No ]
    To measure the level of decisional conflict, subjects were asked to fill out a decisional conflict scale on asthma management which was developed by O'Connor adapted for our study. This questionnaire consisted of 16 questions. The answers used a Likert scale ranged from 1 - strongly agree to 5 - strongly disagree.

Enrollment: 50
Study Start Date: March 2011
Study Completion Date: December 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
DEcisional conflict

Detailed Description:

Asthmatic patients will be recruited and asked to fill a decisional conflict scale.

Patients, asthma educators and physicians will also be recruited to fill a needs assessment questionnaire about decisions taken by asthmatics.


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adults with mild to moderate asthma controlled or slightly controlled


Inclusion Criteria:

  • 18-65 years
  • diagnosed asthma

Exclusion Criteria:

  • received asthma education in the past 2 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01520883

Canada, Quebec
Institut Universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada, G1V 4G5
Sponsors and Collaborators
Laval University
Centre Hospitalier Universitaire de Québec, CHU de Québec
AllerGen NCE Inc.
Principal Investigator: Louis-Philippe Boulet, MD Institut universitaire de cardiologie et de pneumologie de Quebec
  More Information

No publications provided

Responsible Party: Louis-Philippe Boulet, Principal investigator, Laval University Identifier: NCT01520883     History of Changes
Other Study ID Numbers: CER 20646
Study First Received: October 4, 2011
Last Updated: May 24, 2013
Health Authority: Canada: Ethics Review Committee

Additional relevant MeSH terms:
Bronchial Diseases
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases processed this record on March 01, 2015